Search results
HC Wainwright Cuts Sage Therapeutics (NASDAQ:SAGE) Price Target to $25.00
ETF DAILY NEWS· 1 week agoSage Therapeutics (NASDAQ:SAGE – Free Report) had its target price cut by HC Wainwright from $28.00 to $25.00 in a research report sent to investors on ...
Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates
Zacks via Yahoo Finance· 2 weeks agoSage Therapeutics' (SAGE) first-quarter 2024 results are mixed as earnings miss estimates, but sales...
Can Esketamine Prevent Postpartum Depression?
Medscape· 2 weeks agoData suggest that a low dose of esketamine immediately after childbirth reduces major depressive episodes in women with prenatal depression.
Sage Therapeutics Inc (SAGE) Q1 2024 Earnings: Mixed Results Amidst Pipeline Progress
GuruFocus.com via Yahoo Finance· 2 weeks agoR&D Expenses: Research and development expenses amounted to $71.73 million, down from $92.83 million in the previous year. Commercial Progress: ZURZUVAE, for postpartum < ...
Celebrating Utah moms with new efforts to treat maternal mental illness
KSL Salt Lake City· 1 day agoAs Americans celebrate the moms in our lives, health professionals here in Utah are increasing their...
Q2 2024 EPS Estimates for Sage Therapeutics, Inc. Lifted by Analyst (NASDAQ:SAGE)
ETF DAILY NEWS· 1 week agoSage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Wedbush upped their Q2 2024 earnings estimates for Sage Therapeutics in a note ...